產品詳情
簡單介紹：
Anti-ITIH4抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-ITIH4抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-ITIH4
Cat. Number:
Anti-ITIH4抗體KL-9914R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The inter-alpha-trypsin inhibitor (ITI) family is a group of structurally related plasma serine protease inhibitors synthesized in the liver and built up from different combinations of three highly homologous heavy chains (ITI-HI, ITI-H2 and ITI-H3) and one light chain (Bikunin). Another member of the ITI family, ITI-H4, harbors a proline-rich regionAnti-ITIH4抗體 (PRR) in its C-terminus. ITI is a glycoprotein composed of three polypeptides linked by chondroitin sulphate: two heavy chains, ITI-H1 and ITI-H2, and Bikunin. Bikunin confers the protease-inhibitor function of ITI. The heavy chains of the ITI family, designated as SHAPs (for serum-derived hyaluronan-associated proteins), bind covalently to hyaluronic acid (HA), resulting in pericellular matrix stabilization. While the ITI family is primarily composed of multi-polypeptide molecules, ITI-H4 is a single chain molecule. Unlike other ITI family members, the gene transcriptions and products for rat and human ITI-H4 demonstrate marked differences, suggesting possible species-specific functions for ITI-H4. The gene encoding human ITI-H4 maps to chromosome 3p21.1.
Also known as:
ITI-H4; 35 kDa inter-alpha-trypsinAnti-ITIH4抗體 inhibitor heavy chain H4; GP120; H4P; IHRP; Inter-alpha-inhibitor heavy chain 4; Inter-alpha-trypsin inhibitor family heavy chain-related protein; Inter-alpha-trypsin inhibitor heavy chain H4; inter-alpha-trypsin inhibitor, heavy chain-like, 1; ITI heavy chain H4; ITI-HC4; ITIH4; ITIH4_HUMAN; ITIHL1; PK-120; PK120; Plasma kallikrein sensitive glycoprotein 120.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ITIH4.
●
Predicted Molecular Weight: 71kDa.Anti-ITIH4抗體
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications. Anti-ITIH4抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-ITIH4抗體
Optimal working dilutions must be determined by the end user.
kl149Hu01 Ⅳ型膠原α1(COL4α1)多克隆抗體 Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)
kl149Mu01 Ⅳ型膠原α1(COL4α1)多克隆抗體 Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)
kl149Ra01 Ⅳ型膠原α1(COL4α1)多克隆抗體 Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)
kl151Mu01 激肽釋放酶3(KLK3)多克隆抗體 Polyclonal Antibody to Kallikrein 3 (KLK3)
kl151Si01 激肽釋放酶3(KLK3)多克隆抗體 Polyclonal Antibody to Kallikrein 3 (KLK3)
kl154Hu01 糖抗原125(CA125)多克隆抗體 Polyclonal Antibody to Carbohydrate Antigen 125 (CA125)
kl154Mu01 糖抗原125(CA125)多克隆抗體 Polyclonal Antibody to Carbohydrate Antigen 125 (CA125)
kl159Hu01 鱗狀細胞癌抗原2(SCCA2)多克隆抗體 Polyclonal Antibody to Squamous Cell Carcinoma Antigen 2 (SCCA2)
kl159Mu01 鱗狀細胞癌抗原2(SCCA2)多克隆抗體 Polyclonal Antibody to Squamous Cell Carcinoma Antigen 2 (SCCA2)
kl160Bo01 α2-纖溶酶抑制因子(α2PI)多克隆抗體 Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)
kl160Hu01 α2-纖溶酶抑制因子(α2PI)多克隆抗體 Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)
kl160Mu01 α2-纖溶酶抑制因子(α2PI)多克隆抗體 Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)
kl160Ra01 α2-纖溶酶抑制因子(α2PI)多克隆抗體 Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)
kl160Rb51 α2-纖溶酶抑制因子(α2PI)多克隆抗體 Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)
kl162Bo01 嗅素4(OLFM4)多克隆抗體 Polyclonal Antibody to Olfactomedin 4 (OLFM4)
kl162Hu01 嗅素4(OLFM4)多克隆抗體 Polyclonal Antibody to Olfactomedin 4 (OLFM4)
kl162Mu01 嗅素4(OLFM4)多克隆抗體 Polyclonal Antibody to Olfactomedin 4 (OLFM4)
kl164Ga01 泛素(Ub)多克隆抗體 Polyclonal Antibody to Ubiquitin (Ub)
kl164Gu01 泛素(Ub)多克隆抗體 Polyclonal Antibody to Ubiquitin (Ub)
